Stocks and Investing Stocks and Investing
Thu, September 8, 2022
[ 12:00 AM ] - WOPRAI
Michael Lapides Downgraded (WMB) to Strong Sell and Decreased Target to $30 on, Sep 8th, 2022
[ 12:00 AM ] - WOPRAI
Daniel Moore Upgraded (WLY) to Buy on, Sep 8th, 2022
[ 12:00 AM ] - WOPRAI
Daniel Moore Upgraded (WLYB) to Buy on, Sep 8th, 2022
[ 12:00 AM ] - WOPRAI
Bianca Dallal Initiated (WPP) at Hold on, Sep 8th, 2022
[ 12:00 AM ] - WOPRAI
Jeff Cantwell Maintained (WEX) at Buy with Decreased Target to $194 on, Sep 8th, 2022
[ 12:00 AM ] - WOPRAI
Sara Senatore Initiated (WEN) at Buy and Held Target at $25 on, Sep 8th, 2022
[ 12:00 AM ] - WOPRAI
Ken Newman Maintained (WCC) at Buy with Increased Target to $165 on, Sep 8th, 2022
[ 12:00 AM ] - WOPRAI
Jessica Tassan Initiated (ACCD) at Buy and Held Target at $12 on, Sep 8th, 2022
[ 12:00 AM ] - WOPRAI
Suneet Kamath Maintained (AFL) at Hold with Increased Target to $60 on, Sep 8th, 2022
[ 12:00 AM ] - WOPRAI
Mike Genovese Maintained (ADTN) at Strong Buy with Decreased Target to $29 on, Sep 8th, 2022
[ 12:00 AM ] - WOPRAI
Dana Telsey Maintained (AEO) at Hold with Decreased Target to $13 on, Sep 8th, 2022
[ 12:00 AM ] - WOPRAI
Paul Lejuez Maintained (AEO) at Hold with Decreased Target to $10 on, Sep 8th, 2022
[ 12:00 AM ] - WOPRAI
Jonna Kim Maintained (AEO) at Hold with Decreased Target to $11 on, Sep 8th, 2022
[ 12:00 AM ] - WOPRAI
Saket Kalia Maintained (ADBE) at Buy with Decreased Target to $440 on, Sep 8th, 2022
Wed, September 7, 2022
[ 12:00 AM ] - WOPRAI
Chris Pierce Maintained (ACVA) at Strong Buy with Increased Target to $12 on, Sep 7th, 2022
[ 12:00 AM ] - WOPRAI
Jailendra Singh Initiated (ACCD) at Strong Buy and Held Target at $15 on, Sep 7th, 2022
[ 12:00 AM ] - WOPRAI
James Faucette Maintained (ACN) at Buy with Decreased Target to $350 on, Sep 7th, 2022
[ 12:00 AM ] - WOPRAI
Craig Siegenthaler Initiated (AB) at Hold and Held Target at $45 on, Sep 7th, 2022
[ 12:00 AM ] - WOPRAI
Maheep Mandloi Initiated (WBX) at Buy and Held Target at $14 on, Sep 7th, 2022
[ 12:00 AM ] - WOPRAI
Steven Shemesh Initiated (WOOF) at Buy and Held Target at $17 on, Sep 7th, 2022
[ 12:00 AM ] - WOPRAI
Francois Brisebois Initiated (AQST) at Buy and Held Target at $8.5 on, Sep 7th, 2022
[ 12:00 AM ] - WOPRAI
Serge Belanger Initiated (ARQT) at Strong Buy and Held Target at $46 on, Sep 7th, 2022
[ 12:00 AM ] - WOPRAI
Oren Livnat Initiated (ANIP) at Strong Buy and Held Target at $50 on, Sep 7th, 2022
[ 12:00 AM ] - WOPRAI
Craig Siegenthaler Initiated (AMP) at Strong Buy and Held Target at $336 on, Sep 7th, 2022
[ 12:00 AM ] - WOPRAI
Jessica Tassan Maintained (AMWL) at Buy with Decreased Target to $100 on, Sep 7th, 2022
[ 12:00 AM ] - WOPRAI
Jailendra Singh Initiated (AMWL) at Hold and Held Target at $100 on, Sep 7th, 2022
[ 12:00 AM ] - WOPRAI
Jon Hickman Initiated (BLIN) at Strong Buy and Held Target at $4.5 on, Sep 7th, 2022
[ 12:00 AM ] - WOPRAI
Richard Hill Maintained (AMBP) at Hold with Decreased Target to $6.5 on, Sep 7th, 2022
[ 12:00 AM ] - WOPRAI
Thibault Boutherin Initiated (ALVO) at Hold and Held Target at $10 on, Sep 7th, 2022
[ 12:00 AM ] - WOPRAI
Amit Hazan Maintained (BVS) at Hold with Decreased Target to $13 on, Sep 7th, 2022

Amit Hazan Maintained (BVS) at Hold with Decreased Target to $13 on, Sep 7th, 2022


Published on 2024-10-27 22:55:31 - WOPRAI, Amit Hazan
  Print publication without navigation


Amit Hazan of Goldman Sachs, Maintained "Bioventus Inc." (BVS) at Hold with Decreased Target from $15 to $13 on, Sep 7th, 2022.

Amit has made no other calls on BVS in the last 4 months.



There is 1 other peer that has a rating on BVS. Out of the 1 peers that are also analyzing BVS, 0 agree with Amit's Rating of Hold.



This is the rating of the analyst that currently disagrees with Amit

  • Drew Ranieri of "Morgan Stanley" Maintained at Buy with Increased Target to $12 on, Friday, August 12th, 2022
Contributing Sources